Harlow, United Kingdom

Chi Leung Li


Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2009-2015

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Chi Leung Li: Pioneering Innovator Shaping the Future of Technology

Introduction:

Chi Leung Li is a distinguished inventor based in Harlow, GB, renowned for his groundbreaking contributions to the world of innovation. With a proven track record of success, he stands as a beacon of creativity and ingenuity, spearheading advancements that are reshaping the future of technology.

Latest Patents:

One of Chi Leung Li's latest patents is an oral dosage form for controlled drug release. This innovative oral delivery device utilizes ultrasonic cutting in its preparation process, featuring a core containing a pharmaceutically active agent within an outer coating with strategically placed openings for controlled release.

Career Highlights:

Throughout his career, Chi Leung Li has amassed an impressive portfolio of 5 patents, each showcasing his expertise and dedication to pushing the boundaries of technological innovation. Having worked with esteemed companies such as SmithKline Beecham Corporation and GlaxoSmithKline LLC, he has left a lasting impact on the field of pharmaceuticals and drug delivery systems.

Collaborations:

Chi Leung Li has collaborated with notable professionals in the industry, including Luigi Martini and Ronald Raby. These partnerships have not only fostered a culture of collaboration and knowledge exchange but have also led to the development of innovative solutions that address critical challenges in the field.

Conclusion:

In conclusion, Chi Leung Li's unwavering commitment to innovation, coupled with his strong work ethic and visionary mindset, sets him apart as a pioneering inventor shaping the landscape of technology. His contributions to the field have not only revolutionized drug delivery systems but have also inspired a new wave of creativity and advancement in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…